Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Versiti rolls out antibody tests to screen for COVID-19 vaccine-related blood clots
Forget the competition. Sanofi still plans to usher its COVID-19 shot across the finish line
Can Regeneron make 'monoclonal antibodies' a catchphrase? New COVID-19 ad campaign gives it a go
Physician assistants report COVID-19 furloughs and burnout, but remain optimistic for profession's future
Illumina pledges $60M in genomic sequencing expertise to help launch global outbreak-tracking network
COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show
VA, CDC data suggest low-severity COVID-19 patients will need follow-up care
Lonza taps temporary workers from Nestlé in COVID shot production push: report
UPDATED Coronavirus tracker: HHS turns to community health centers, local leaders to maintain vaccine momentum

Featured Story

Versiti rolls out antibody tests to screen for COVID-19 vaccine-related blood clots

By Conor Hale

Versiti’s blood tests screen for antibodies that may make typical clot treatments harmful to help healthcare providers choose alternative therapies.

Forget the competition. Sanofi still plans to usher its COVID-19 shot across the finish line

By Eric Sagonowsky

With a half-dozen COVID-19 vaccines on the market or close to it, one of the world's top vaccine players called it quits after R&D delays and setbacks. But not Sanofi. The company still thinks its shot can help meet global demand.

Can Regeneron make 'monoclonal antibodies' a catchphrase? New COVID-19 ad campaign gives it a go

By Beth Snyder Bulik

Regeneron wants people to know monoclonal antibodies are ready and willing to treat COVID-19—and it's fielding a national ad campaign to tell them. The campaign includes four TV ads targeting U.S. regions where infection rates are highest.

Physician assistants report COVID-19 furloughs and burnout, but remain optimistic for profession's future

By Dave Muoio

A national survey of more than 20,000 physician assistants outlined work disruptions and COVID-19 specialty changes, yet many respondents said they do not believe the pandemic will have a negative impact on the profession.

Illumina pledges $60M in genomic sequencing expertise to help launch global outbreak-tracking network

By Andrea Park

Amid the havoc wreaked around the world by the COVID-19 pandemic, the race is on to build better protections against future outbreaks. After dipping its toe in these waters with the launch of a pathogen-tracking initiative in Africa, Illumina is now fully diving in with a five-year commitment to a global version.

COVID-19 Tracker

Featured Story

Versiti rolls out antibody tests to screen for COVID-19 vaccine-related blood clots

Top Stories

Forget the competition. Sanofi still plans to usher its COVID-19 shot across the finish line

Can Regeneron make 'monoclonal antibodies' a catchphrase? New COVID-19 ad campaign gives it a go

Physician assistants report COVID-19 furloughs and burnout, but remain optimistic for profession's future

Illumina pledges $60M in genomic sequencing expertise to help launch global outbreak-tracking network

COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show

VA, CDC data suggest low-severity COVID-19 patients will need follow-up care

Lonza taps temporary workers from Nestlé in COVID shot production push: report

UPDATED Coronavirus tracker: HHS turns to community health centers, local leaders to maintain vaccine momentum